Stock Earnings

Question 1

Reviva Pharmaceuticals Holdings, Inc.の主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、PTT Exploration and Production Public Company Limitedの総資産は$933,936で、純이익は$60,273です。

Question 2

RVPHWの主要な財務比率は何ですか？

Accepted Answer

PTT Exploration and Production Public Company Limitedの流動比率は2.25、純利益率は21.41、1株当たり売上高は$70.89です。

Question 3

Reviva Pharmaceuticals Holdings, Inc.の収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

PTT Exploration and Production Public Company Limited 주요 수익원은 Exploration and Production이며, 최신 수익 발표에서 수익은 322,895,000,000입니다. 지역별로는 Thailand이 PTT Exploration and Production Public Company Limited의 주요 시장이며, 수익은 190,682,000,000입니다.

Question 4

Reviva Pharmaceuticals Holdings, Inc.は収益を上げていますか？

Accepted Answer

예、最新の財務諸表によると、PTT Exploration and Production Public Company Limitedの純이익は$60,273です。

Question 5

Reviva Pharmaceuticals Holdings, Inc.に負債はありますか？

Accepted Answer

예、PTT Exploration and Production Public Company Limitedの負債は414,631です。

Question 6

Reviva Pharmaceuticals Holdings, Inc.の発行済株式数は何株ですか？

Accepted Answer

PTT Exploration and Production Public Company Limitedの総発行済株式数は3,969.98株です。

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
매출	281,448	281,448	312,310	300,693	331,350	219,068
매출 성장률 (YoY)	-10%	-10%	4%	-9%	51%	37%
매출원가	62,167	62,167	63,350	58,295	63,229	44,718
매출총이익	219,281	219,281	248,959	242,397	268,120	174,349
판매비와관리비	20,222	20,222	18,114	16,979	20,386	11,416
연구개발 비용	4,344	4,344	4,382	3,308	2,551	7,109
영업비용	119,760	119,760	117,536	101,609	106,105	88,820
기타 비영업 수익(비용)	5,301	5,301	6,085	5,031	6,984	4,337
세전수익(EBT)	104,106	104,106	136,031	140,408	143,196	80,391
법인세비용	43,850	43,850	57,214	63,703	72,294	41,528
순이익	60,273	60,273	78,824	76,706	71,232	38,517
순이익 성장률	-24%	-24%	3%	8%	85%	72%
발행주(희석)	3,970	3,970	3,970	3,970	3,970	3,970
주식 변화 (YoY)	0%	0%	0%	0%	0%	0%
EPS (희석주당이익)	15.18	15.18	19.85	19.32	17.94	9.7
EPS 성장률	-24%	-24%	3%	8%	85%	72%
잉여현금흐름	26,374	26,374	77,135	68,667	98,737	56,665
주당 잉여현금흐름	--	--	--	--	--	--
매출총이익률	77.91%	77.91%	79.71%	80.61%	80.91%	79.58%
영업이익률	35.35%	35.35%	42.08%	46.82%	48.89%	39.04%
이익률	21.41%	21.41%	25.23%	25.5%	21.49%	17.58%
잉여현금흐름마진	9.37%	9.37%	24.69%	22.83%	29.79%	25.86%
EBITDA	194,713	194,713	226,461	222,109	245,182	155,822
EBITDA 마진	69.18%	69.18%	72.51%	73.86%	73.99%	71.12%
D&A for EBITDA	95,193	95,193	95,039	81,321	83,168	70,293
EBIT	99,520	99,520	131,422	140,788	162,014	85,529
EBIT 마진	35.35%	35.35%	42.08%	46.82%	48.89%	39.04%
실질 세율	42.12%	42.12%	42.05%	45.36%	50.48%	51.65%

Reviva Pharmaceuticals Holdings, Inc. (RVPHW) 재무

RVPHW 주가 차트

주요 통계

이전 종가

시가

일일 범위

52주 범위

거래량

평균 거래량

배당수익률

EPS(TTM)

시가총액

RVPHW 소득

Follow-Up Questions